Eszopiclone has been developed for the treatment of insomnia in adults. Insomnia is difficulty getting to sleep or staying asleep for long enough to feel refreshed the next morning. It is a common problem thought to regularly affect around one in every three people in the UK and is particularly common in elderly people. Insomnia is comorbid with several conditions, such as rheumatoid arthritis, depression and menopause. Insomnia has a negative impact on a wide range of daytime functions, including social, emotional, and physical domains, and chronic insomnia affects cognitive and physical functioning.
Eszopiclone for treating insomnia
Eszopiclone has been developed for the treatment of insomnia in adults. Insomnia is difficulty getting to sleep or staying asleep for long enough to feel refreshed the next morning.